We next investigated the effects of our panel of kinase inhibitors on primary AML and CMML cells, including those expressing mutant CBL, as well as those expressing wt FLT3/wt CBL, and mutant FLT3/wt CBL. This evidence concerns the gene CBL and acute myeloid leukemia.